AKT1 and renal fibrosis: Transplanted MSCs ameliorate renal fibrosis by hampering the fibrotic signaling pathways, and mainly inhibit the activation of TGF-β1/Smads, NF-κB, and ERK (as the main subsets of MAPK signaling), PI3K/AKT.